AiVita Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AiVita Biomedical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11060
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AiVita Biomedical Inc (AiVita) is a biotechnology company developing novel stem cell technologies to develop cell-based treatments and healthcare products for the treatment of cancer, vision loss, and skincare formulations. Its lead therapeutic candidate is a patient-specific immunotherapy for the treatment of advanced cancers, glioblastoma and ovarian cancer. The company’s preclinical programs include human stem cells differentiated into sheets of retinal tissue to treat degenerative retinal diseases; and anti-aging skin care technology. AiVita is focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. AiVita Biomedical is headquartered in Irvine, California, the US.

AiVita Biomedical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AiVita Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
AiVita Biomedical Raises USD15 Million in Series B Financing 10
AiVita Biomedical Raises Additional USD3.5 Million in Venture Financing 11
AiVita Biomedical Raises USD2 Million in Series A Financing 12
Licensing Agreements 13
Caladrius Biosciences Enters into Licensing Agreement with AiVita Biomedical 13
AiVita Biomedical Enters into Licensing Agreement with Caladrius Biosciences 14
AiVita Biomedical Inc – Key Competitors 15
AiVita Biomedical Inc – Key Employees 16
AiVita Biomedical Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Aug 16, 2018: AIVITA Biomedical appoints chief financial officer and vice president of business development 18
Sep 21, 2017: Renowned Dermatologist Dr. Michael H. Gold Joins AIVITA Scientific Advisory Board 19
May 03, 2017: AIVITA Biomedical names Ed Inal as Chief Operating Officer 20
Government and Public Interest 21
Jul 17, 2018: AIVITA Biomedical receives $1.7 million CIRM Grant to treat Vision loss 21
Sep 19, 2017: AIVITA Biomedical Announces New Discovery with Applications to Regenerative Medicine, Skin Aging and Hair Growth 22
Product News 23
Jun 14, 2018: AIVITA Biomedical Randomizes First Patient in Phase II Ovarian Cancer Trial 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Key Facts 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AiVita Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AiVita Biomedical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AiVita Biomedical Raises USD15 Million in Series B Financing 10
AiVita Biomedical Raises Additional USD3.5 Million in Venture Financing 11
AiVita Biomedical Raises USD2 Million in Series A Financing 12
Caladrius Biosciences Enters into Licensing Agreement with AiVita Biomedical 13
AiVita Biomedical Enters into Licensing Agreement with Caladrius Biosciences 14
AiVita Biomedical Inc, Key Competitors 15
AiVita Biomedical Inc, Key Employees 16

List of Figures
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[AiVita Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NuGEN Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company provides DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DN …
  • Lund University-製薬・医療分野:企業M&A・提携分析
    Summary Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The universi …
  • Japan Wind Development Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Japan Wind Development Co Ltd (JWD) is a renewable energy company that operates and develops wind power generation plants. The company offers operation and maintenance, construction and development of wind power plants. It also develops green power system integration technology. JWD’s power …
  • OSI Systems, Inc. (OSIS):企業の財務・戦略的SWOT分析
    OSI Systems, Inc. (OSIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sabre Corporation (SABR):企業の財務・戦略的SWOT分析
    Sabre Corporation (SABR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kennametal Inc.:戦略・SWOT・企業財務分析
    Kennametal Inc. - Strategy, SWOT and Corporate Finance Report Summary Kennametal Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • TVS Motor Co Ltd:戦略・SWOT・企業財務分析
    TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vitasoy International Holdings Limited (345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Limited (345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Avedro Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • Tokyo Electron Limited:企業の戦略・SWOT・財務分析
    Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Inovise Medical, Inc.:企業の戦略的SWOT分析
    Inovise Medical, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • One Lambda Inc:医療機器:M&Aディール及び事業提携情報
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device manufacturing company that offers laboratory products. The company develops and distributes antibody detection products and histocompatibility typing tests. Its products include HLA testing reagents …
  • Kansai Nerolac Paints Ltd:企業の戦略・SWOT・財務情報
    Kansai Nerolac Paints Ltd - Strategy, SWOT and Corporate Finance Report Summary Kansai Nerolac Paints Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Del Taco Holdings, Inc.:企業の戦略・SWOT・財務情報
    Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kayson Inc:企業の戦略・SWOT・財務分析
    Kayson Inc - Strategy, SWOT and Corporate Finance Report Summary Kayson Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • ENN Energy Holdings Ltd (2688):企業の財務・戦略的SWOT分析
    ENN Energy Holdings Ltd (2688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Barnes & Noble Education Inc (BNED):企業の財務・戦略的SWOT分析
    Barnes & Noble Education Inc (BNED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tellurian Inc (TELL):石油・ガス:M&Aディール及び事業提携情報
    Summary Tellurian Inc (Tellurian), formerly Magellan Petroleum Corp, is an oil and gas company that provides exploration, development, and production of crude oil and natural gas. The company develops liquefied natural gas production and export terminal on the west bank of the Calcasieu River, south …
  • Eurofins Scientific SE (ERF):企業の財務・戦略的SWOT分析
    Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Affymetrix, Inc.-医療機器分野:企業M&A・提携分析
    Summary Affymetrix, Inc. (Affymetrix) provides life science, and molecular diagnostic products for analysis of biological systems at gene, protein and cellular level. It offers products for two major applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆